174 related articles for article (PubMed ID: 9881747)
1. Structural features of the human salivary mucin, MUC7.
Gururaja TL; Ramasubbu N; Venugopalan P; Reddy MS; Ramalingam K; Levine MJ
Glycoconj J; 1998 May; 15(5):457-67. PubMed ID: 9881747
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of O-glycosylated C-terminal leucine zipper domain of human salivary mucin (MUC7).
Narasimhamurthy S; Naganagowda GA; Janagani S; Gururaja TL; Levine MJ
J Biomol Struct Dyn; 2000 Aug; 18(1):145-54. PubMed ID: 11021659
[TBL] [Abstract][Full Text] [Related]
3. NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.
Naganagowda GA; Gururaja TL; Satyanarayana J; Levine MJ
J Pept Res; 1999 Oct; 54(4):290-310. PubMed ID: 10532235
[TBL] [Abstract][Full Text] [Related]
4. Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1.
Gururaja TL; Levine JH; Tran DT; Naganagowda GA; Ramalingam K; Ramasubbu N; Levine MJ
Biochim Biophys Acta; 1999 Apr; 1431(1):107-19. PubMed ID: 10209284
[TBL] [Abstract][Full Text] [Related]
5. Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7.
Satyanarayana J; Situ H; Narasimhamurthy S; Bhayani N; Bobek LA; Levine MJ
J Pept Res; 2000 Nov; 56(5):275-82. PubMed ID: 11095181
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and conformational features of human salivary mucin C-terminal derived peptide epitope carrying Thomsen-Friedenreich antigen: implications for its role in self-association.
Satyanarayana J; Gururaja TL; Narasimhamurthy S; Naganagowda GA; Levine MJ
Biopolymers; 2001 Apr; 58(5):500-10. PubMed ID: 11241221
[TBL] [Abstract][Full Text] [Related]
7. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
[TBL] [Abstract][Full Text] [Related]
8. Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity.
Situ H; Wei G; Smith CJ; Mashhoon S; Bobek LA
Biochem J; 2003 Oct; 375(Pt 1):175-82. PubMed ID: 12812519
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity and poly-L-proline II conformation of the tandem repeat sequence of human salivary mucin glycoprotein (MG2).
Antonyraj KJ; Karunakaran T; Raj PA
Arch Biochem Biophys; 1998 Aug; 356(2):197-206. PubMed ID: 9705210
[TBL] [Abstract][Full Text] [Related]
10. Structure and biosynthesis of human salivary mucins.
Zalewska A; Zwierz K; Zółkowski K; Gindzieński A
Acta Biochim Pol; 2000; 47(4):1067-79. PubMed ID: 11996097
[TBL] [Abstract][Full Text] [Related]
11. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
Gerken TA
Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
[TBL] [Abstract][Full Text] [Related]
12. Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association.
Mehrotra R; Thornton DJ; Sheehan JK
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):415-22. PubMed ID: 9716500
[TBL] [Abstract][Full Text] [Related]
13. N-terminal diproline and charge group effects on the stabilization of helical conformation in alanine-based short peptides: CD studies with water and methanol as solvent.
Goyal B; Srivastava KR; Durani S
J Pept Sci; 2017 Jun; 23(6):431-437. PubMed ID: 28425159
[TBL] [Abstract][Full Text] [Related]
14. Two-hybrid analysis of human salivary mucin MUC7 interactions.
Bruno LS; Li X; Wang L; Soares RV; Siqueira CC; Oppenheim FG; Troxler RF; Offner GD
Biochim Biophys Acta; 2005 Oct; 1746(1):65-72. PubMed ID: 16203048
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.
Situ H; Bobek LA
Antimicrob Agents Chemother; 2000 Jun; 44(6):1485-93. PubMed ID: 10817697
[TBL] [Abstract][Full Text] [Related]
16. Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core.
Kinarsky L; Suryanarayanan G; Prakash O; Paulsen H; Clausen H; Hanisch FG; Hollingsworth MA; Sherman S
Glycobiology; 2003 Dec; 13(12):929-39. PubMed ID: 12925576
[TBL] [Abstract][Full Text] [Related]
17. Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.
Fontenot JD; Tjandra N; Bu D; Ho C; Montelaro RC; Finn OJ
Cancer Res; 1993 Nov; 53(22):5386-94. PubMed ID: 8221676
[TBL] [Abstract][Full Text] [Related]
18. Salivary mucin MUC7 oligosaccharides in patients with recurrent aphthous stomatitis.
Zad M; Flowers SA; Bankvall M; Jontell M; Karlsson NG
Clin Oral Investig; 2015 Nov; 19(8):2147-52. PubMed ID: 26051835
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine model of candidiasis.
Intini G; Aguirre A; Bobek LA
Int J Antimicrob Agents; 2003 Dec; 22(6):594-600. PubMed ID: 14659657
[TBL] [Abstract][Full Text] [Related]
20. Recent evolution of the salivary mucin MUC7.
Xu D; Pavlidis P; Thamadilok S; Redwood E; Fox S; Blekhman R; Ruhl S; Gokcumen O
Sci Rep; 2016 Aug; 6():31791. PubMed ID: 27558399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
